Skip to main content
The medtech role in the different phases of the pandemic.
In vitro diagnostics at risk: Covid-19 delays progresses towards the new European regulations
26 Nov 2020
Chair of the Regulatory IVD Forum of Confindustria Dispositivi Medici
In order to keep them available to the health care system and to patients, more than 85% of IVDs will need to be updated in view of the new in vitro Diagnostic...
Planning ahead – with clear data
30 Oct 2020
Kathleen Van Vlierberghe
Senior Director, Healthcare Solutions and Partnerships, EMEA at Boston Scientific
With more than 45 million confirmed cases and more than 1 million deaths at the time of writing, the coronavirus pandemic has wreaked havoc in virtually all...
COPD & COVID-19: Pandemic must prompt shift to connected care
26 Oct 2020
Vice President, EMEA Marketing at ResMed
For people living with chronic obstructive pulmonary disease (COPD), a long-term lung illness, COVID-19 is having a major impact. The pandemic has disrupted...
The implications of COVID-19 on recruiting in the Life Science sector
26 Oct 2020
Global Head of Talent Attraction & Acquisition at Thermo Fisher Scientific
We’re at the heart of the global response to COVID-19, a powerful reminder of our mission to enable our customers to make the world healthier,cleaner and safer...
In crisis, medtech found the path to realise its full potential
20 Oct 2020
Senior Vice President and President, EMEA - Boston Scientific
I have been truly humbled by the collective response of the medical technology industry through this pandemic. As we approach MedTech Week 2020, our industry...